Loading…
Treatment of thyroid tumor Japanese clinical guidelines /
Creating clinical guidelines is a modern trend. Published studies pertaining to a given theme are collected, their credibility evaluated, and then treatment options in the form of evidence-based guidelines are offered. There are a number of guidelines for the treatment of thyroid tumors that have es...
Saved in:
Corporate Author: | |
---|---|
Other Authors: | , |
Format: | eBook |
Language: | English Japanese |
Published: |
Tokyo ; New York :
Springer,
©2013.
Tokyo ; New York : [2013] |
Physical Description: |
1 online resource. |
Subjects: | |
Online Access: | SpringerLink - Click here for access |
Contents:
- Part 1. Epidemiology
- CQ1. What Are the Risk Factors for Thyroid Cancer?
- CQ2. Is There a Difference in Prognosis Between Adult Thyroid Cancer and Juvenile Thyroid Cancer or Juvenile Follicular Cancer?
- Column 1. Genetics of Thyroid Cancer
- Column 2. Prevalence of Various Histological Types of Thyroid Cancer
- Column 3. Anaplastic Transformation of Differentiated Carcinoma
- Column 4. Incidence, Morbidity, and Mortality of Thyroid Carcinoma in Japan.
- Part 2. Diagnosis and non-surgical management\n
- CQ3. What Is the Frequency (Probability of Cancer Before Examination) of Thyroid Cancer
- CQ4. What Are the Factors That Increase the Likelihood of Malignancy and What Is the Odds Ratio and Risk Ratio?
- CQ5. What Are the Physical Signs and Symptoms That Increase the Likelihood of Thyroid Cancer and What Are the Sensitivity and Specificity?
- CQ6. What Are the Imaging Studies Most Suitable for the Diagnosis of Thyroid Carcinoma and What Are Their Sensitivity, Specificity, and Likelihood Ratio?
- CQ7. What Are the Blood Chemistry Data That Increase the Likelihood of Thyroid Malignancy and What Are Their Sensitivity, Specificity, and Likelihood Ratio?
- CQ8. What Are the Sensitivity and Specificity of Aspiration Cytology?
- CQ9. What Are the Sensitivity and Specificity of Ultrasonography, CT, MRI, Laryngoscopy, and Bronchoscopy in the Preoperative Evaluation of Thyroid Cancer Invasion to the Trachea, Esophagus, and the Recurrent Laryngeal Nerve?
- CQ10. How Is the Natural History of Nodules Diagnosed as Benign (Growth and Reduction Rates)?
- CQ11. Does TSH Suppression Therapy Reduce the Size of Tumors Diagnosed as Benign?
- CQ12. What Is the Intra-Observer Variation in the Pathological Diagnosis of Follicular Carcinoma?
- CQ13. What Is the Efficacy of Percutaneous Ethanol Injection Therapy for Autonomously Functioning Thyroid Nodules?
- CQ14. Do Cystic Nodules Decrease in Volume by Aspiration and Drainage of Content Fluid and Percutaneous Ethanol Injection Therapy?
- CQ15. What Is the Likelihood That Multinodular Goiter Will Be Surgically Resected After Observation?
- Column 5. Indication for Surgery of Nodular Goiter
- Column 6. Diagnosis of Anaplastic Carcinoma.
- Part 3. Papillary carcinoma
- CQ16. What Is the Most Appropriate and Convenient Risk Classification System for Predicting the Prognosis of Patients with Papillary Carcinoma?
- CQ17. Does Total (or Near Total) Thyroidectomy Improve the Prognosis of Papillary Carcinoma Patients Compared to Lobectomy or Lobectomy Isthmectomy?
- CQ18. Does Central Compartment Dissection Improve the Prognosis of Papillary Carcinoma Patients?
- CQ19. Does Dissection of the Lateral Compartment Improve the Prognosis of Papillary Carcinoma Patients?
- CQ20. When Can Papillary Microcarcinoma (Papillary Carcinoma Measuring 1 cm or Less) Be Observed Without Immediate Surgery?
- Column 7. What Is the Acceptable Incidence for Persistent Recurrent Laryngeal Nerve Paralysis and Persistent Hypoparathyroidism as Complications of Thyroid Surgery?
- Column 8. The Controversy Regarding the Extent of Thyroidectomy for Papillary Carcinoma and Actual Practice in Japan
- Column 9. Lobectomy and Paratracheal Node Dissection.
- Part 4. Follicular tumor
- Introduction
- CQ21. Is It Possible to Diagnose Follicular Carcinoma on Preoperative FNA or Intraoperative Frozen Section Diagnosis?
- CQ22. Does Classification of Follicular Carcinoma According to the Degree of Invasiveness (Widely Invasive and Minimally Invasive Types) Reflect the Prognosis?
- CQ23. When Is Completion Total Thyroidectomy Recommended as a Second Surgery for Patients Who Underwent Hemithyroidectomy and Were Diagnosed as Having Follicular Carcinoma on Postoperative Pathological Examination?
- CQ24. Does Total Thyroidectomy with Radioactive Iodine Ablation and TSH Suppression Therapy Improve Patient Prognosis with Widely Invasive Follicular Carcinoma Compared to Only Limited Thyroidectomy?
- CQ25. Does Prognosis of Oxyphilic (Hurthle Cell) Follicular Carcinoma Differ from That of Conventional Follicular Carcinoma?
- Part 5. Medullary carcinoma
- CQ26. What Is the Usefulness of RET Gene Mutation Analysis for Medullary Carcinoma?
- CQ27. What Are the Incidences of Diseases Associated with Hereditary Medullary Carcinoma?
- CQ28. Do Total Thyroidectomy and Lymph Node Dissection for Sporadic and Hereditary Medullary Carcinoma Improve the Prognosis?
- CQ29. Is Chemotherapy Effective for Advanced or Relapsed Medullary Carcinoma?
- CQ30. What Are Prognostic Factors of Medullary Carcinoma?
- Part 6. Poorly differentiated carcinoma
- CQ31. What Is the Definition of Poorly Differentiated Carcinoma? What Is Its Prevalence and Prognosis?
- CQ32. Can Poorly Differentiated Carcinoma Be Diagnosed Preoperatively?
- CQ33. Do Total Thyroidectomy and Prophylactic Lymph Node Dissection Improve the Prognosis of Patients with Poorly Differentiated Carcinoma?
- CQ34. Does Additional Surgery Improve the Prognosis of Patients Who Underwent Hemithyroidectomy Under a Diagnosis of Papillary or Follicular Carcinoma, But Who Are Later Diagnosed as Having Poorly Differentiated Carcinoma on Postoperative Pathological Examination?
- CQ35. Do Therapies Other Than Surgery Improve the Prognosis for Patients with Poorly Differentiated Carcinoma?
- Column 10. Carcinoma Showing Thymus-Like Differentiation/Intrathyroidal Epithelial Thymoma.
- Part 7. Anaplastic carcinoma
- Introduction
- CQ36. Does Surgical Treatment for Anaplastic Carcinoma Improve Prognosis?
- CQ37. Do Adjuvant Therapies Improve the Prognosis of Anaplastic Carcinoma in Patients Who Underwent Curative Surgery?
- CQ38. Does Combined Modality Therapy for Anaplastic Carcinoma Improve Prognosis?
- CQ39. Should Relapsed Lesions of Differentiated Carcinoma That Were Diagnosed as Anaplastic Carcinoma Be Treated as Anaplastic Carcinoma?
- Column 11. When Should Palliative Care Be Considered? Is the Prognosis Explained to Patients?
- Column 12. Squamous Cell Carcinoma of the Thyroid Is Currently Classified as a Different Histology from Anaplastic Carcinoma. Are Therapeutic Strategies and Prognosis of Squamous Cell Carcinoma Similar to Those of Anaplastic Carcinoma?
- Part 8. Radiation therapy
- CQ40. What Are Applications and Roles of Ablation?
- CQ41. Is Iodine Restriction Necessary Before Ablation?
- CQ42. What Is the Appropriate Dose of 131I?
- CQ43. What Is the Benefit of RAI Therapy for Local Recurrence, Lymph Node Metastasis and Distant Metastasis of Differentiated Thyroid Carcinoma?
- CQ44. What Is the Application, Effect and Safety of Recombinant Human Thyroid Stimulating Hormone (rhTSH)?
- Column 13. Comments on RAI Therapy Including the Actual Situation in Japan
- Column 14. Applications for External Beam Radiotherapy for Differentiated Thyroid Carcinoma
- Column 15. Is it Appropriate to 131I Scintigraphy Before RAI Therapy? What Is the Dose?
- Column 16. What Is the Actual Status of Radiotherapy (External Beam Radiotherapy and 131I MIBG Therapy)?
- Column 17. What Are the Side Effects of RAI Therapy and What Is Their Frequency?
- Part 9. Surgical Treatment for Advanced Differentiated Carcinoma
- CQ45. What Is the Indication for Resection of the Recurrent Laryngeal Nerve for Cases Extending There?
- CQ46. Is Phonetic Function Improved by Reconstruction of the Recurrent Laryngeal Nerve?
- CQ47. For Cases Extending to the Trachea, Does Sleeve Resection of the Trachea Improve the Survival Rate Compared to Partial Resection (Wedge Resection or Window Resection)?
- CQ48. Does Tracheal Resection Improve the Survival Rate Compared with No Resection?
- Column 18. Treatment and Management Approaches for Cases Extending to the Trachea with Larynx, Esophagus, or Mediastinum Involvement.
- Part 10. Postoperative observation of differentiated carcinoma and treatment for inoperable cases
- CQ49. Does TSH Suppression Therapy After Surgery for Differentiated Thyroid Carcinoma Improve Survival?
- CQ50. Is Serum Thyroglobulin Measurement Useful as a Marker of Carcinoma Recurrence After Surgery?
- CQ51. Are Measurements of Calcitonin and CEA Useful as Markers of Recurrence After Surgery for Medullary Carcinoma?
- CQ52. What Are Useful Imaging Studies to Detect Lesions of Recurrence for Medullary Carcinoma with Elevation of Postoperative Calcitonin Level?
- CQ53. Is Chemotherapy for Advanced Thyroid Carcinoma Effective?
- CQ54. Is Percutaneous Ethanol Injection Therapy Effective for Local or Lymph Node Recurrence and Bone Metastasis?
- CQ55. Are Alternate Therapies Effective for Thyroid Carcinoma?
- Column 19. How Long Should Patients with Differentiated Thyroid Carcinoma Be Followed After Surgery?